I 

116TH CONGRESS 

2D SESSION H. R. 7507 

To authorize the Secretary of Health and Human Services to award grants 

to States to expand or maintain a strategic stockpile of products deemed 

to be essential in the event of a public health emergency, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 9, 2020 

Mr. CARTER of Georgia (for himself and Mr. O’HALLERAN) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To authorize the Secretary of Health and Human Services 

to award grants to States to expand or maintain a strategic stockpile of products deemed to be essential in 

the event of a public health emergency, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘State Stockpile Readi5 ness Act of 2020’’. 


pamtmann on DSKBC07HB2PROD with BILLS
2 

•HR 7507 IH

1 SEC. 2. GRANTS FOR STATE STRATEGIC STOCKPILES. 

2 Title III of the Public Health Service Act is amended 

3 by inserting after section 319F–4 of such Act (42 U.S.C. 

4 247d–6e) the following new section: 

5 ‘‘SEC. 319F–5. GRANTS FOR STATE STRATEGIC STOCKPILES. 

6 ‘‘(a) IN GENERAL.—The Secretary may establish a 

7 pilot program consisting of awarding grants to States to 

8 expand or maintain a strategic stockpile of commercially 

9 available drugs, medical equipment, personal protective 

10 equipment, and other products deemed by the State to be 

11 essential in the event of a public health emergency. 

12 ‘‘(b) ALLOWABLE USE OF FUNDS.— 

13 ‘‘(1) USES.—A State receiving a grant under 

14 this section may use the grant funds to— 

15 ‘‘(A) acquire commercially available prod16 ucts listed pursuant to paragraph (2) for inclu17 sion in the State’s strategic stockpile; 

18 ‘‘(B) store, maintain, and distribute prod19 ucts in such stockpile; and 

20 ‘‘(C) conduct planning in connection with 

21 such activities. 

22 ‘‘(2) LIST.—The Secretary shall develop and 

23 publish a list of the products that are eligible, as de24 scribed in subsection (a), for inclusion in a State’s 

25 strategic stockpile using funds received under this 

26 section. 


pamtmann on DSKBC07HB2PROD with BILLS
3 

•HR 7507 IH

1 ‘‘(3) CONSULTATION.—In developing the list 

2 under paragraph (2) and otherwise determining the 

3 allowable uses of grant funds under this section, the 

4 Secretary shall consult with States and relevant 

5 stakeholders, including public health organizations. 

6 ‘‘(c) FUNDING REQUIREMENT.—The Secretary may 

7 not obligate or expend any funds to award grants or fund 

8 any previously awarded grants under this section for a fis9 cal year unless the total amount made available to carry 

10 out section 319F–2 for such fiscal year is equal to or 

11 greater than the total amount of funds made available to 

12 carry out section 319F–2 for fiscal year 2020. 

13 ‘‘(d) MATCHING FUNDS.— 

14 ‘‘(1) IN GENERAL.—With respect to the costs of 

15 expanding and maintaining a strategic stockpile 

16 through a grant under this section, as a condition on 

17 receipt of the grant, a State shall make available (di18 rectly) non-Federal contributions in cash toward 

19 such costs in an amount that is equal to not less 

20 than the amount of Federal funds provided through 

21 the grant. 

22 ‘‘(2) WAIVER.—The Secretary may waive the 

23 requirement of paragraph (1) with respect to a State 

24 for the first two years of the State receiving a grant 

25 under this section if the Secretary determines that 


pamtmann on DSKBC07HB2PROD with BILLS
4 

•HR 7507 IH

1 such waiver is needed for the State to establish a 

2 strategic stockpile described in subsection (a). 

3 ‘‘(e) TECHNICAL ASSISTANCE.—The Secretary shall 

4 provide technical assistance to States in establishing, ex5 panding, and maintaining a stockpile described in sub6 section (a). 

7 ‘‘(f) DEFINITION.—In this section, the term ‘drug’ 

8 has the meaning given to that term in section 201 of the 

9 Federal Food, Drug, and Cosmetic Act. 

10 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—To 

11 carry out this section, there is authorized to be appro12 priated $3,500,000,000 for each of fiscal years 2020 

13 through 2023, to remain available until expended. 

14 ‘‘(h) SUNSET.—The authority vested by this section 

15 terminates at the end of fiscal year 2023.’’. 

Æ 


pamtmann on DSKBC07HB2PROD with BILLS